Adult Hypertension Prevalence 47.7 Percent From August 2021 to August 2023
By Elana Gotkine HealthDay Reporter
WEDNESDAY, Oct. 23, 2024 -- During August 2021 to August 2023, the prevalence of adult hypertension was 47.7 percent, with hypertension higher in men than women, according to an October data brief published by the National Center for Health Statistics.
Cheryl D. Fryar, M.S.P.H., from the National Center for Health Statistics in Hyattsville, Maryland, and colleagues used data from the National Health and Nutrition Examination Survey to examine the prevalence, awareness, treatment, and control of hypertension among U.S. adults during August 2021 to August 2023.
The researchers found that the prevalence of adult hypertension was 47.7 percent during August 2021 to August 2023. Hypertension was higher in men than women (50.8 versus 44.6 percent) and increased with age: 23.4, 52.5, and 71.6 percent for ages 18 to 39, 40 to 59, and 60 years and older, respectively. Overall, 59.2 percent of those with hypertension were aware of their hypertension status. Of adults with hypertension, 51.2 percent were currently taking medication to lower blood pressure. One-fifth (20.7 percent) of adults with hypertension had their blood pressure controlled to less than 130/80 mm Hg. From 2017-March 2020 to August 2021-August 2023, there was no significant change seen in awareness, treatment, or control of hypertension.
"Based on recent national data from August 2021 through August 2023, the prevalence of hypertension remains above the Healthy People 2030 target goal to lower blood pressure to 41.9 percent of the population or below," the authors write. "However, the prevalence of controlled hypertension at 20.7 percent is higher than the Healthy People 2030 target goal of 18.9 percent or above."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted October 2024
Read this next
GLP-1 Receptor Agonists May Improve Outcomes in Idiopathic Intracranial Hypertension
MONDAY, July 21, 2025 -- For patients with idiopathic intracranial hypertension (IIH), glucagon-like peptide 1 receptor agonist (GLP-1 RA) treatment is associated with improved...
ENDO: Primary Aldosteronism Screening Recommended for All With Hypertension
FRIDAY, July 18, 2025 -- All individuals with hypertension should be screened for primary aldosteronism (PA), according to a clinical practice guideline issued by the Endocrine...
Delays in HTN Diagnosis Linked to Delays in Medication Prescribing
THURSDAY, July 17, 2025 -- Delays in diagnosis of hypertension are common and associated with delays in treatment initiation, according to a study published online July 14 in JAMA...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.